Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Ablaze Medicine Partners with Oncoshot for AI-based Optimization of Clinical Trials

publication date: Dec 22, 2023

Zhejiang Ablaze Medicine, a Hangzhou company that provides services for clinical trials, formed a partnership with Singapore’s Oncoshot, a company applying AI to streamline clinical trials. Recently, Ablaze has expanded into data management and clinical trials recruitment. Oncoshot offers data analysis and insights that improve clinical trials. Together, the two companies expect to use AI to transform the speed, efficiency and accessibility of global drug development programs. After 20 years of aiding clinical trials, Ablaze now facilitates over 200 global customers across four continents to optimize research outcomes. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital